An atypical cutaneous reaction to rivastigmine transdermal patch.

Author: CalvieriS, De MarcoI, FainaV, GriecoT, PigattoP, RossiM

Paper Details 
Original Abstract of the Article :
Rivastigmine is a cholinesterase inhibitor which improves cognitive function and is currently being used in patients with mild to moderate Parkinson's and Alzheimer's dementia. This drug can be given orally or topically, as transdermal patch. The latter form is currently used for most excellent comp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025363/

データ提供:米国国立医学図書館(NLM)

A Case of Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch

The use of [rivastigmine] for treating [Alzheimer's dementia] has become increasingly common. This case report describes an unusual cutaneous reaction to [rivastigmine transdermal patch] in a patient with [Alzheimer's dementia]. The patient experienced a [sensitization reaction] to the patch, highlighting the importance of recognizing potential allergic responses to this medication.

Rivastigmine: A Potential Allergen

This case report provides valuable information about the potential for allergic reactions to [rivastigmine transdermal patch]. While [irritative dermatitis] is a common side effect, this patient's experience highlights the possibility of more severe allergic reactions. It is important for healthcare professionals to be aware of this potential and monitor patients closely for any signs of sensitization.

Navigating the Desert of Allergic Reactions

Imagine a vast desert where [rivastigmine transdermal patch] is a vital source of water for individuals suffering from [Alzheimer's dementia]. This case report brings to light the potential for allergic reactions to this medication, akin to encountering a patch of poisonous plants in the desert. By understanding this potential, healthcare providers can navigate this terrain with greater awareness and ensure the safety of their patients.

Dr.Camel's Conclusion

This case report, like a warning sign in a desert landscape, reminds us of the importance of vigilance when using [rivastigmine transdermal patch]. While this medication can be a valuable tool for treating [Alzheimer's dementia], it is essential to remain alert to the possibility of allergic reactions and provide appropriate care to patients.

Date :
  1. Date Completed 2011-07-14
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21274348

DOI: Digital Object Identifier

PMC3025363

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.